NDC 65841-836

bupropion

Bupropion

bupropion is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Bupropion Hydrochloride.

Product ID65841-836_3609dfc8-06c4-40ad-9265-7a784eee5596
NDC65841-836
Product TypeHuman Prescription Drug
Proprietary Namebupropion
Generic NameBupropion
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2018-08-02
Marketing CategoryANDA / ANDA
Application NumberANDA201567
Labeler NameCadila Healthcare Limited
Substance NameBUPROPION HYDROCHLORIDE
Active Ingredient Strength150 mg/1
Pharm ClassesAminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 65841-836-05

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-836-05)
Marketing Start Date2018-08-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65841-836-05 [65841083605]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA201567
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-02

NDC 65841-836-10 [65841083610]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA201567
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-02

NDC 65841-836-06 [65841083606]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA201567
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-02

NDC 65841-836-16 [65841083616]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA201567
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-02

Drug Details

Active Ingredients

IngredientStrength
BUPROPION HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:78d34aad-9d4f-48c4-91eb-536e31c6b6c9
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 993557
  • 993541

    • Pharmacological Class

    • Aminoketone [EPC]
    • Dopamine Uptake Inhibitors [MoA]
    • Increased Dopamine Activity [PE]
    • Increased Norepinephrine Activity [PE]
    • Norepinephrine Uptake Inhibitors [MoA]

    NDC Crossover Matching brand name "bupropion" or generic name "Bupropion"

    NDCBrand NameGeneric Name
    0615-8262bupropionbupropion hydrochloride
    43547-288bupropionBupropion hydrochloride
    43547-289bupropionbupropion hydrochloride
    43547-290bupropionbupropion hydrochloride
    50090-3854bupropionbupropion hydrochloride
    50436-0289bupropionbupropion hydrochloride
    51655-357bupropionbupropion hydrochloride
    54868-5927Bupropionbupropion hydrochloride
    55700-644bupropionbupropion hydrochloride
    63187-521bupropionbupropion
    63629-8036bupropionbupropion hydrochloride
    65841-780bupropionbupropion
    65841-836bupropionbupropion
    67046-699BupropionBupropion
    68001-264bupropionbupropion
    68071-5214bupropionbupropion hydrochloride
    68382-353bupropionbupropion
    68382-354bupropionbupropion
    68788-7249bupropionbupropion
    68788-9255bupropionbupropion
    70518-1644bupropionbupropion
    71335-0801bupropionbupropion
    71335-0785bupropionbupropion
    70934-151bupropionbupropion
    68788-7283bupropionbupropion
    70518-2641bupropionbupropion
    71335-1622bupropionbupropion
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.